Table 5.
Impact of CMR on patient management by indication
| Myocarditis/CMP | Suspected CAD/Ischemia | Viability | |
|---|---|---|---|
| All (from n = 27781) |
32.2% |
34.2% |
14.6% |
| Completely new diagnosis not suspected before |
11.4% |
8.1% |
5.3% |
| Therapeutic consequences |
|
|
|
| Change in medication |
25.3% |
24.3% |
33.2% |
| Invasive procedure |
6.9% |
23.1% |
24.2% |
| Hospital discharge |
10.4% |
14.3% |
6.9% |
| Hospital admission |
1.1% |
1.5% |
1.9% |
| Impact on patient management (new diagnosis and/or therapeutic consequence) | 55.1% | 71.4% | 71.5% |